Healios K.K. (TYO:4593)
Japan · Delayed Price · Currency is JPY 645.00
+23.00 (3.70%)
Aug 5, 2025, 3:30 PM JST
Healios K.K. Revenue
Healios K.K. had revenue of 38.00M JPY in the quarter ending March 31, 2025, with 280.00% growth. This brings the company's revenue in the last twelve months to 588.00M, up 374.19% year-over-year. In the year 2024, Healios K.K. had annual revenue of 560.00M with 362.81% growth.
Revenue (ttm)
588.00M
Revenue Growth
+374.19%
P/S Ratio
107.33
Revenue / Employee
9.05M
Employees
65
Market Cap
63.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 560.00M | 439.00M | 362.81% |
| Dec 31, 2023 | 121.00M | 31.00M | 34.44% |
| Dec 31, 2022 | 90.00M | 49.00M | 119.51% |
| Dec 31, 2021 | 41.00M | 14.00M | 51.85% |
| Dec 31, 2020 | 27.00M | -252.00M | -90.32% |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Daiichi Sankyo Company | 1,924.68B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Otsuka Holdings | 2,393.18B |
| Terumo | 1,036.17B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |